Skip navigation

Advanced Strategies for Navigating a Complex Regulatory Landscape and Managing High-Priority Risks in the Asia-Pacific Region

February 27-28, 2020
  • Kyoto, Japan

Rapidly evolving global regulations are deeply affecting business operations in Asia, especially as the pharmaceutical and medical device markets grow in this region. With the U.S., UK and local Asian regulatory bodies increasing their ABAC enforcements, multinational life sciences companies must be more vigilant than ever. Compliance professionals are tasked with building and maintaining effective compliance programs to meet these multi-jurisdictional requirements while still aligning with the needs of the business.

Informa Connect’s Life Sciences Compliance Congress Asia is the only event for compliance teams, providing novel approaches and advanced strategies for this quickly transforming regulatory landscape. This fully-packed two-day forum provides the ideal opportunity for professionals to benchmark, exchange ideas and learn about impact of the latest laws and regulations surrounding bribery and corruption, HCP sponsorships, transparency, data privacy, promotional activities, third-party management and more.

Spark Connections with Compelling Content and Discourse:

  • Ethics and compliance as a strategic business partner
  • The behavioral science behind compliance
  • Adapting compliance to the digital solutions
    adopted by the business
  • Market updates — Country-by-country regulatory changes
    and what they mean for compliance
  • Anti-bribery and anti-corruption efforts in Japan, China,
    South Korea and other countries in the region
  • Transparency reporting requirements in South Korea, Japan,
    Indonesia and The Philippines
  • Digitalization and automation for compliance monitoring
    and auditing
  • Global data protection and cybersecurity trends
  • Disruptive technologies impacting compliance efforts,
    including Artificial Intelligence and machine learning
  • Third-party risk oversight and management
  • And more!

PREVIOUS PARTICIPATING COMPANIES INCLUDE:

Boehringer Ingelheim Dentsply Sirona Sanofi Taiho Pharmaceutical
Pfizer Inc GlaxoSmithKline Hemas Pharmaceuticals
Bristol-Myers Squibb Otsuka Pharmaceutical  Sandoz Merck KGaA
Ortho Clinical Diagnostics MSD Merck Novo Nordisk Eli Lilly Amgen
Beigene Novartis Becton, Dickinson and Company Allergan
Abbvie Eisai Co Celgene Medtronic

Questions to be Discussed in 2020:

  • How do you setup compliance training programs as an
    ongoing practice to increase compliance awareness
    throughout your organization?
  • How will the automation and digital solutions impact
    your compliance program?
  • How can compliance support business intelligence
    through data analytics? And partner with business units
    to achieve organizational goals?
  • Are compliance and ethics initiatives part of your
    companies’ broader mission?

Download the Conference Preview

Previous Attendee Acclaim:

CBI always provides insightful speakers who share their worldly experience on important healthcare topics.

Senior Director, Compliance, GlaxoSmithKline

Life Sciences Compliance Congress Asia

Advanced Strategies for Navigating a Complex Regulatory Landscape and Managing High-Priority Risks in the Asia-Pacific Region

Rapidly evolving global regulations are deeply affecting business operations in Asia, especially as the pharmaceutical and medical device markets grow in this region. With the U.S., UK and local Asian regulatory bodies increasing their ABAC enforcements, multinational life sciences companies must be more vigilant than ever. Compliance professionals are tasked with building and maintaining effective compliance programs to meet these multi-jurisdictional requirements while still aligning with the needs of the business.

Informa Connect’s Life Sciences Compliance Congress Asia is the only event for compliance teams, providing novel approaches and advanced strategies for this quickly transforming regulatory landscape. This fully-packed two-day forum provides the ideal opportunity for professionals to benchmark, exchange ideas and learn about impact of the latest laws and regulations surrounding bribery and corruption, HCP sponsorships, transparency, data privacy, promotional activities, third-party management and more.

Spark Connections with Compelling Content and Discourse:

  • Ethics and compliance as a strategic business partner
  • The behavioral science behind compliance
  • Adapting compliance to the digital solutions
    adopted by the business
  • Market updates — Country-by-country regulatory changes
    and what they mean for compliance
  • Anti-bribery and anti-corruption efforts in Japan, China,
    South Korea and other countries in the region
  • Transparency reporting requirements in South Korea, Japan,
    Indonesia and The Philippines
  • Digitalization and automation for compliance monitoring
    and auditing
  • Global data protection and cybersecurity trends
  • Disruptive technologies impacting compliance efforts,
    including Artificial Intelligence and machine learning
  • Third-party risk oversight and management
  • And more!

PREVIOUS PARTICIPATING COMPANIES INCLUDE:

Boehringer Ingelheim Dentsply Sirona Sanofi Taiho Pharmaceutical
Pfizer Inc GlaxoSmithKline Hemas Pharmaceuticals
Bristol-Myers Squibb Otsuka Pharmaceutical  Sandoz Merck KGaA
Ortho Clinical Diagnostics MSD Merck Novo Nordisk Eli Lilly Amgen
Beigene Novartis Becton, Dickinson and Company Allergan
Abbvie Eisai Co Celgene Medtronic

Questions to be Discussed in 2020:

  • How do you setup compliance training programs as an
    ongoing practice to increase compliance awareness
    throughout your organization?
  • How will the automation and digital solutions impact
    your compliance program?
  • How can compliance support business intelligence
    through data analytics? And partner with business units
    to achieve organizational goals?
  • Are compliance and ethics initiatives part of your
    companies’ broader mission?

Download the Conference Preview

Previous Attendee Acclaim:

CBI always provides insightful speakers who share their worldly experience on important healthcare topics.

Senior Director, Compliance, GlaxoSmithKline